Rahel Nussbaumer1,2, Anne Christin Meyer-Gerspach1,3, Ralph Peterli1,2, Thomas Peters4, Christoph Beglinger1, Sonja Chiappetta5, Juergen Drewe6, Bettina Wölnerhanssen7,8. 1. University of Basel, Basel, Switzerland. 2. Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Claraspital and University Hospital, Basel, Switzerland. 3. St. Clara Research Ltd., St. Claraspital, Basel, Switzerland. 4. Department of Medicine, St. Claraspital, Basel, Switzerland. 5. Department of Obesity and Metabolic Surgery, Ospedale Evangelico Betania, Naples, Italy. 6. Department of Pharmacology and Toxicology, University Hospital, Basel, Switzerland. 7. University of Basel, Basel, Switzerland, bettina.woelnerhanssen@unibas.ch. 8. St. Clara Research Ltd., St. Claraspital, Basel, Switzerland, bettina.woelnerhanssen@unibas.ch.
Abstract
BACKGROUND: Most patients with severe obesity show glucose intolerance. Early after sleeve gastrectomy (LSG) or gastric bypass (LRYGB), a marked amelioration in glycemic control occurs. The underlying mechanism is not yet clear. OBJECTIVE: To determine whether the improvement in glycemic control on the level of endocrine pancreatic function is due to an increased first-phase insulin secretion comparing LRYGB to LSG. SETTING: University of Basel Hospital and St. Clara Research Ltd., Basel, Switzerland. METHODS:Sixteen morbidly obese patients with severe obesity and different degrees of insulin resistance were randomized to LSG or LRYGB, and islet cell functions were tested by intravenous glucose and intravenous arginine administration before and 4 weeks after surgery. RESULTS:Fasting insulin and glucose levels and homeostasis model assessment insulin resistance were significantly lower in both groups after surgery compared to baseline, while no change was seen in fasting C-peptide, amylin, and glucagon. After intravenous glucose stimulation, no statistically significant pre- to postoperative change in area under the curve (AUC 0-60 min) was seen for insulin, glucagon, amylin, and C-peptide. No statistically significant pre- to postoperative change in incremental AUC for first-phase insulin release (AUC 0-10 min), second-phase insulin secretion (AUC 10-60 min), and insulin/glucose ratio could be shown in either group. Arginine-stimulated insulin and glucagon release showed no pre- to postoperative change. CONCLUSION: Intravenous glucose and arginine administrations show no pre- to postoperative changes of insulin release, amylin, glucagon, or C-peptide concentrations, and no differences between LRYGB and LSG were found. The postoperative improvement in glycemic control is not caused by changes in endocrine pancreatic hormone secretion.
RCT Entities:
BACKGROUND: Most patients with severe obesity show glucose intolerance. Early after sleeve gastrectomy (LSG) or gastric bypass (LRYGB), a marked amelioration in glycemic control occurs. The underlying mechanism is not yet clear. OBJECTIVE: To determine whether the improvement in glycemic control on the level of endocrine pancreatic function is due to an increased first-phase insulin secretion comparing LRYGB to LSG. SETTING: University of Basel Hospital and St. Clara Research Ltd., Basel, Switzerland. METHODS: Sixteen morbidly obesepatients with severe obesity and different degrees of insulin resistance were randomized to LSG or LRYGB, and islet cell functions were tested by intravenous glucose and intravenous arginine administration before and 4 weeks after surgery. RESULTS: Fasting insulin and glucose levels and homeostasis model assessment insulin resistance were significantly lower in both groups after surgery compared to baseline, while no change was seen in fasting C-peptide, amylin, and glucagon. After intravenous glucose stimulation, no statistically significant pre- to postoperative change in area under the curve (AUC 0-60 min) was seen for insulin, glucagon, amylin, and C-peptide. No statistically significant pre- to postoperative change in incremental AUC for first-phase insulin release (AUC 0-10 min), second-phase insulin secretion (AUC 10-60 min), and insulin/glucose ratio could be shown in either group. Arginine-stimulated insulin and glucagon release showed no pre- to postoperative change. CONCLUSION: Intravenous glucose and arginine administrations show no pre- to postoperative changes of insulin release, amylin, glucagon, or C-peptide concentrations, and no differences between LRYGB and LSG were found. The postoperative improvement in glycemic control is not caused by changes in endocrine pancreatic hormone secretion.
Authors: N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti Journal: Surg Endosc Date: 2011-06-03 Impact factor: 4.584
Authors: A C Gerspach; R E Steinert; L Schönenberger; A Graber-Maier; C Beglinger Journal: Am J Physiol Endocrinol Metab Date: 2011-05-03 Impact factor: 4.310
Authors: Jonathan D Roth; Todd Coffey; Carolyn M Jodka; Holly Maier; Jennifer R Athanacio; Christine M Mack; Christian Weyer; David G Parkes Journal: Endocrinology Date: 2007-08-30 Impact factor: 4.736
Authors: James L Trevaskis; Todd Coffey; Rebecca Cole; Chunli Lei; Carrie Wittmer; Brandon Walsh; Christian Weyer; Joy Koda; Alain D Baron; David G Parkes; Jonathan D Roth Journal: Endocrinology Date: 2008-07-31 Impact factor: 4.736
Authors: April D Strader; Torsten P Vahl; Ronald J Jandacek; Stephen C Woods; David A D'Alessio; Randy J Seeley Journal: Am J Physiol Endocrinol Metab Date: 2004-09-28 Impact factor: 4.310
Authors: Ralph Peterli; Robert E Steinert; Bettina Woelnerhanssen; Thomas Peters; Caroline Christoffel-Courtin; Markus Gass; Beatrice Kern; Markus von Fluee; Christoph Beglinger Journal: Obes Surg Date: 2012-05 Impact factor: 4.129
Authors: Francesco M Carrano; Angelo Iossa; Nicola Di Lorenzo; Gianfranco Silecchia; Katerina-Maria Kontouli; Dimitris Mavridis; Isaias Alarçon; Daniel M Felsenreich; Sergi Sanchez-Cordero; Angelo Di Vincenzo; M Carmen Balagué-Ponz; Rachel L Batterham; Nicole Bouvy; Catalin Copaescu; Dror Dicker; Martin Fried; Daniela Godoroja; David Goitein; Jason C G Halford; Marina Kalogridaki; Maurizio De Luca; Salvador Morales-Conde; Gerhard Prager; Andrea Pucci; Ramon Vilallonga; Iris Zani; Per Olav Vandvik; Stavros A Antoniou Journal: Surg Endosc Date: 2022-01-20 Impact factor: 4.584